# LEVOCETIRIZINE DIHYDROCHLORIDE
> **ANDA211551** · Abbreviated New Drug Application (Generic) · Sponsor: SANKALP LIFECARE · Approved 2018-11-20
## Drug
- **FDA Application Number:** ANDA211551
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Generic name:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Active ingredients:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** SANKALP LIFECARE
- **Manufacturer:** VELOCITY PHARMA LLC
- **First approval:** 2018-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211551)
---
*MORVS · CC0 1.0*